- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04992767
Online Intervention to Promote Resilience to Traumatic Stress During Pregnancy
March 17, 2025 updated by: Jennifer Duffecy, University of Illinois at Chicago
The investigators will design, construct, and pilot a prototype of a trauma-informed online intervention, which will be called "SunnysideFlex," that functionally integrates a web-based intervention targeting skills to decrease symptoms of PTSD and better manage mood during and after pregnancy.
SunnysideFlex will build upon the previously IRB-approved "Sunnyside" intervention which targeted skills to manage mood through an interactive website with didactic material and tools.
Women in weeks 16-28 of their pregnancy who self-report symptoms of PTSD will be randomized to one of three study groups: (1) SunnysideFlex, (2) the original Sunnyside intervention (active control), or (3) treatment as usual (TAU).
The SunnysideFlex intervention will consist of 6 weeks of trauma-informed online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum.
Outcomes will be measured at baseline, post-intervention, 6 weeks postpartum, and 12 weeks postpartum.
SunnysideFlex has the potential to provide a novel paradigm for improving maternal and child health outcomes in high-risk, trauma-exposed women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60607
- University of Illinois Department of Psychology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Female
- 18 years and older
- Pregnant and between 16-28 weeks gestation
- Are currently engaged in prenatal care with a healthcare provider (OB/GYN, nurse, midwife, etc.)
- Endorse a history of one or more potentially traumatic events meeting Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Criterion A for PTSD (i.e., "exposure to actual or threatened death, serious injury, or sexual violence," American Psychological Association [APA], p. 271) that is interpersonal in nature (e.g., sexual or physical assault, child abuse/maltreatment, witnessing family violence)
- Endorse a score of 33 or greater on the PTSD Checklist for DSM-5 (PCL-5)
- Have access to a broadband internet connection
- Able to read and speak English
Exclusion Criteria:
- Pregnant with multiples
- Have visual, hearing, voice, or motor impairment that would prevent completion of study procedures
- Have been diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, substance use disorder, or other diagnosis for which participation in this trial is either inappropriate or dangerous based on self-report
- Report currently being in an abusive or unsafe relationship
- Currently receiving treatment (medication or psychotherapy), or have an intention to resume antidepressant medication after delivery (i.e., women who discontinued their medication during pregnancy)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Sunnyside
An online intervention to better manage mood during and after pregnancy.
|
The Sunnyside intervention is an online intervention(an interactive website with didactic material and interactive tools) targeting skills to manage mood during and after pregnancy.
The Sunnyside intervention will consist of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum.
Each lesson takes approximately 10 minutes to complete.
|
|
Experimental: SunnysideFlex
An online intervention to treat symptoms of PTSD and better manage mood during and after pregnancy.
|
SunnysideFlex consists of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum.
SunnysideFlex has adapted the original Sunnyside intervention with revised, trauma-focused content that covers the impact of PTSD symptoms on the perinatal period and daily functioning, more broadly
|
|
No Intervention: Treatment as Usual
A control condition consisting of standard prenatal medical care, without provision of the SunnysideFlex or Sunnyside intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PTSD Checklist for DSM-5 (PCL-5)
Time Frame: Past 30 days
|
The PCL-5 is a well validated screening tool for assessing PTSD symptoms and probable PTSD diagnosis.
the PCL-5 checklist assesses frequency of past 30-day PTSD symptoms in reference to an individual's self-identified worst traumatic event.
A total score of 33 or greater represents a positive PTSD screen and is the cut-off employed in the current study.
|
Past 30 days
|
|
Impact of Events Scale - Revised (IES-R)
Time Frame: 1 week
|
The IES-R assesses the past-week frequency of PTSD symptoms in reference to the participant's self-identified worst traumatic event
|
1 week
|
|
Patient Health Questionnaire-9 (PHQ-9)
Time Frame: 2 weeks
|
Reflects overall functioning and impairment due to the depressive symptoms.
PHQ-9 scoring interpretations are as follows: 1-4: minimal depressive symptoms; 5-9 mild depressive symptoms; 10-14: moderate depressive symptoms; 15-19: moderately severe depressive symptoms: 20-27: severe depressive symptoms.
|
2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jennifer Duffecy, PhD, University of Illinois at Chicago
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 21, 2022
Primary Completion (Actual)
April 19, 2024
Study Completion (Actual)
October 2, 2024
Study Registration Dates
First Submitted
July 28, 2021
First Submitted That Met QC Criteria
July 28, 2021
First Posted (Actual)
August 5, 2021
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 17, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021-0002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
The University of Texas Health Science Center at...The University of Texas at San AntonioCompleted
-
Gynuity Health ProjectsCuidado Integral de la Mujer, Gineclinic, S.C.; Servicios de Salud Medieg,...Not yet recruitingPregnancy Related | Pregnancy Early
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Portucalense UniversityAveiro University; Unidade Local de Saúde do Alto Ave, EPERecruiting
-
Oregon Health and Science UniversityNot yet recruitingPregnancy Related
-
Oregon Health and Science UniversityRecruiting
-
Biorithm Pte LtdNot yet recruitingPregnancy Related
Clinical Trials on Sunnyside
-
University of Illinois at ChicagoCompletedDepression | BreastfeedingUnited States